Issues related to medication therapy management
H.R.3 - Elijah E. Cummings Lower Drug Costs Now Act
S.2543 - Prescription Drug Pricing Reduction Act of 2019
S. 724/H.R. 1614, the John S. McCain Opioid Addiction Prevention Act
COVID relief proposals
Issues related to Drug Enforcement Agency and its efforts on prescription drug abuses and diversion.
Pharmacy issues within TriCARE
Issues related to scope of services for pharmacists
H.R.3 - Elijah E. Cummings Lower Drug Costs Now Act
S.2543 - Prescription Drug Pricing Reduction Act of 2019
S. 724/H.R. 1614, the John S. McCain Opioid Addiction Prevention Act
COVID relief proposals
Duration: January 1, 2016
to
December 31, 2020
General Issues: Medicare/Medicaid , Pharmacy
Spending: about $1,080,000 (But it's complicated. Here's why.)
It can be tricky to figure out how much an organization spent on a particular lobbying engagement. The law only requires lobbyists to report the amount they were paid for federal lobbying each quarter rounded to the nearest $10,000—and if it's less than $3,000 in a given quarter (or less than $13,000 for organizations with in-house lobbyists), they don't have to disclose it at all. Plus, some organizations include spending that doesn’t belong in the report—for instance, money spent lobbying state governments or other legal work.
Agencies lobbied since 2016: U.S. Senate, Health & Human Services - Dept of (HHS), House of Representatives
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Lobbyist
Covered positions?
Robert Holifield Staff Director, Senate Agriculture Committee; Staff Director, Senate Finance Subcmte on Int'l Trade; Deputy Chief of Staff, CFTC; Director of External Affairs, CFTC
Blanche Lincoln U.S. Senator and Congresswoman -- Arkansas
Hannah Lambiotte Smith Legislative Correspondent, Sen. Blanche Lincoln; Legislative Assistant; Sen. Blanche Lincoln; Staff Director, Senate Finance Subcmte Trade
Mac Campbell Deputy Staff Director, Senate Finance Committee; General Counsel, Senate Finance Committee; Legislative Director, Sen. Maria Cantwell; Tax Counsel and Legislative Assistant, Sen. Blanche Lincoln
Craig Felner Legislative Assistant, Sen. Kay Bailey Hutchison; Associate Director, White House Office of Cabinet Affairs.
Dan Elling Staff Director, Ways and Means Health Subcommittee; Professional Staff, Ways and Means Health Subcommittee; Health Policy Aide, Rep. Nancy Johnson; Legislative Assistant, Rep. Jim Ramstad
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
4th Quarter, 2020
Lincoln Policy Group terminated an engagement in which they represented National Association of Chain Drug Stores on Jan. 21, 2021.
Original Filing: 301244117.xml
Lobbying Issues
Issues related to medication therapy management
H.R.3 - Elijah E. Cummings Lower Drug Costs Now Act
S.2543 - Prescription Drug Pricing Reduction Act of 2019
S. 724/H.R. 1614, the John S. McCain Opioid Addiction Prevention Act
COVID relief proposals
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to Drug Enforcement Agency and its efforts on prescription drug abuses and diversion.
Pharmacy issues within TriCARE
Issues related to scope of services for pharmacists
H.R.3 - Elijah E. Cummings Lower Drug Costs Now Act
S.2543 - Prescription Drug Pricing Reduction Act of 2019
S. 724/H.R. 1614, the John S. McCain Opioid Addiction Prevention Act
COVID relief proposals
Agencies Lobbied
U.S. Senate
3rd Quarter, 2020
In Q3, Lincoln Policy Group lobbied for National Association of Chain Drug Stores , earning $60,000. The report was filed on Oct. 20, 2020.
Original Filing: 301221038.xml
Lobbying Issues
Issues related to medication therapy management
H.R.3 - Elijah E. Cummings Lower Drug Costs Now Act
S.2543 - Prescription Drug Pricing Reduction Act of 2019
S. 724/H.R. 1614, the John S. McCain Opioid Addiction Prevention Act
COVID relief proposals
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to Drug Enforcement Agency and its efforts on prescription drug abuses and diversion.
Pharmacy issues within TriCARE
Issues related to scope of services for pharmacists
H.R.3 - Elijah E. Cummings Lower Drug Costs Now Act
S.2543 - Prescription Drug Pricing Reduction Act of 2019
S. 724/H.R. 1614, the John S. McCain Opioid Addiction Prevention Act
COVID relief proposals
Agencies Lobbied
U.S. Senate
2nd Quarter, 2020
In Q2, Lincoln Policy Group lobbied for National Association of Chain Drug Stores , earning $60,000. The report was filed on July 20, 2020.
Original Filing: 301196688.xml
Lobbying Issues
Issues related to medication therapy management
H.R.3 - Elijah E. Cummings Lower Drug Costs Now Act
S.2543 - Prescription Drug Pricing Reduction Act of 2019
S. 724/H.R. 1614, the John S. McCain Opioid Addiction Prevention Act
Paycheck Protection Program and Healthcare Enhancement Act (CARES Act 2.0) (H.R. 266)
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to Drug Enforcement Agency and its efforts on prescription drug abuses and diversion.
Pharmacy issues within TriCARE
Issues related to scope of services for pharmacists
H.R.3 - Elijah E. Cummings Lower Drug Costs Now Act
S.2543 - Prescription Drug Pricing Reduction Act of 2019
S. 724/H.R. 1614, the John S. McCain Opioid Addiction Prevention Act
Paycheck Protection Program and Healthcare Enhancement Act (CARES Act 2.0) (H.R. 266)
Agencies Lobbied
U.S. Senate
1st Quarter, 2020
In Q1, Lincoln Policy Group lobbied for National Association of Chain Drug Stores , earning $60,000. The report was filed on April 20, 2020.
Original Filing: 301176118.xml
Lobbying Issues
Issues related to medication therapy management
H.R.3 - Elijah E. Cummings Lower Drug Costs Now Act
S.2543 - Prescription Drug Pricing Reduction Act of 2019
S. 724/H.R. 1614, the John S. McCain Opioid Addiction Prevention Act
Outreach related to emergency provider status for pharmacists within CARES Act (H.R. 748/S. 3548--Coronavirus Aid, Relief, and Economic Security Act)
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to Drug Enforcement Agency and its efforts on prescription drug abuses and diversion.
Pharmacy issues within TriCARE
Issues related to scope of services for pharmacists
H.R.3 - Elijah E. Cummings Lower Drug Costs Now Act
S.2543 - Prescription Drug Pricing Reduction Act of 2019
S. 724/H.R. 1614, the John S. McCain Opioid Addiction Prevention Act
Outreach related to emergency provider status for pharmacists within CARES Act (H.R. 748/S. 3548--Coronavirus Aid, Relief, and Economic Security Act)
Agencies Lobbied
U.S. Senate
4th Quarter, 2019
In Q4, Lincoln Policy Group lobbied for National Association of Chain Drug Stores , earning $60,000. The report was filed on Jan. 21, 2020.
Original Filing: 301125213.xml
Lobbying Issues
Issues related to medication therapy management
H.R.3 - Elijah E. Cummings Lower Drug Costs Now Act
S.2543 - Prescription Drug Pricing Reduction Act of 2019
S. 724/H.R. 1614, the John S. McCain Opioid Addiction Prevention Act
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to Drug Enforcement Agency and its efforts on prescription drug abuses and diversion.
Pharmacy issues within TriCARE
Issues related to scope of services for pharmacists
H.R.3 - Elijah E. Cummings Lower Drug Costs Now Act
S.2543 - Prescription Drug Pricing Reduction Act of 2019
S. 724/H.R. 1614, the John S. McCain Opioid Addiction Prevention Act
Agencies Lobbied
U.S. Senate
3rd Quarter, 2019
In Q3, Lincoln Policy Group lobbied for National Association of Chain Drug Stores , earning $60,000. The report was filed on Oct. 21, 2019.
Original Filing: 301075212.xml
Lobbying Issues
Issues related to Medicaid pharmacy reimbursement and services access
Issues related to medication therapy management
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to Drug Enforcement Agency and its efforts on prescription drug abuses and diversion.
Comprehensive Drug Addiction and Recovery Act (S. 524)
Pharmacy issues within TriCARE
Issues related to scope of services for pharmacists
Agencies Lobbied
U.S. Senate
2nd Quarter, 2019
In Q2, Lincoln Policy Group lobbied for National Association of Chain Drug Stores , earning $60,000. The report was filed on July 22, 2019.
Original Filing: 301054853.xml
Lobbying Issues
Issues related to Medicaid pharmacy reimbursement and services access
Issues related to medication therapy management
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to Drug Enforcement Agency and its efforts on prescription drug abuses and diversion.
Comprehensive Drug Addiction and Recovery Act (S. 524)
Pharmacy issues within TriCARE
Issues related to scope of services for pharmacists
Agencies Lobbied
U.S. Senate
1st Quarter, 2019
In Q1, Lincoln Policy Group lobbied for National Association of Chain Drug Stores , earning $60,000. The report was filed on April 22, 2019.
Original Filing: 301033613.xml
Lobbying Issues
Issues related to Medicaid pharmacy reimbursement and services access
Issues related to medication therapy management
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to Drug Enforcement Agency and its efforts on prescription drug abuses and diversion.
Comprehensive Drug Addiction and Recovery Act (S. 524)
Pharmacy issues within TriCARE
Issues related to scope of services for pharmacists
Agencies Lobbied
U.S. Senate
4th Quarter, 2018
In Q4, Lincoln Policy Group lobbied for National Association of Chain Drug Stores , earning $50,000. The report was filed on Jan. 22, 2019.
Original Filing: 301013705.xml
Lobbying Issues
Issues related to Medicaid pharmacy reimbursement and services access
Issues related to medication therapy management
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to Drug Enforcement Agency and its efforts on prescription drug abuses and diversion.
Comprehensive Drug Addiction and Recovery Act (S. 524)
Pharmacy issues within TriCARE
Issues related to scope of services for pharmacists
Agencies Lobbied
U.S. Senate
3rd Quarter, 2018
In Q3, Lincoln Policy Group lobbied for National Association of Chain Drug Stores , earning $50,000. The report was filed on Oct. 22, 2018.
Original Filing: 300995916.xml
Lobbying Issues
Issues related to Medicaid pharmacy reimbursement and services access
Issues related to medication therapy management
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to Drug Enforcement Agency and its efforts on prescription drug abuses and diversion.
Comprehensive Drug Addiction and Recovery Act (S. 524)
Pharmacy issues within TriCARE
Issues related to scope of services for pharmacists
Agencies Lobbied
U.S. Senate
2nd Quarter, 2018
In Q2, Lincoln Policy Group lobbied for National Association of Chain Drug Stores , earning $50,000. The report was filed on July 20, 2018.
Original Filing: 300973439.xml
Lobbying Issues
Issues related to Medicaid pharmacy reimbursement and services access
Issues related to medication therapy management
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to Drug Enforcement Agency and its efforts on prescription drug abuses and diversion.
Comprehensive Drug Addiction and Recovery Act (S. 524)
Pharmacy issues within TriCARE
Issues related to scope of services for pharmacists
Agencies Lobbied
U.S. Senate
1st Quarter, 2018
In Q1, Lincoln Policy Group lobbied for National Association of Chain Drug Stores , earning $50,000. The report was filed on April 20, 2018.
Original Filing: 300956659.xml
Lobbying Issues
Issues related to Medicaid pharmacy reimbursement and services access
Issues related to medication therapy management
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to Drug Enforcement Agency and its efforts on prescription drug abuses and diversion.
Comprehensive Drug Addiction and Recovery Act (S. 524)
Pharmacy issues within TriCARE
Issues related to scope of services for pharmacists
Agencies Lobbied
U.S. Senate
4th Quarter, 2017
In Q4, Lincoln Policy Group lobbied for National Association of Chain Drug Stores , earning $50,000. The report was filed on Jan. 22, 2018.
Original Filing: 300934549.xml
Lobbying Issues
Issues related to Medicaid pharmacy reimbursement and services access
Issues related to medication therapy management
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to Drug Enforcement Agency and its efforts on prescription drug abuses and diversion.
Comprehensive Drug Addiction and Recovery Act (S. 524)
Pharmacy issues within TriCARE
Issues related to scope of services for pharmacists
Agencies Lobbied
U.S. Senate
3rd Quarter, 2017
In Q3, Lincoln Policy Group lobbied for National Association of Chain Drug Stores , earning $50,000. The report was filed on Oct. 20, 2017.
Original Filing: 300913684.xml
Lobbying Issues
Issues related to Medicaid pharmacy reimbursement and services access
Issues related to medication therapy management
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to Drug Enforcement Agency and its efforts on prescription drug abuses and diversion.
Comprehensive Drug Addiction and Recovery Act (S. 524)
Pharmacy issues within TriCARE
Issues related to scope of services for pharmacists
Agencies Lobbied
U.S. Senate
2nd Quarter, 2017
In Q2, Lincoln Policy Group lobbied for National Association of Chain Drug Stores , earning $50,000. The report was filed on July 20, 2017.
Original Filing: 300895087.xml
Lobbying Issues
Issues related to Medicaid pharmacy reimbursement and services access
Issues related to medication therapy management
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to Drug Enforcement Agency and its efforts on prescription drug abuses and diversion.
Comprehensive Drug Addiction and Recovery Act (S. 524)
Pharmacy issues within TriCARE
Issues related to scope of services for pharmacists
Agencies Lobbied
U.S. Senate
1st Quarter, 2017
In Q1, Lincoln Policy Group lobbied for National Association of Chain Drug Stores , earning $50,000. The report was filed on April 20, 2017.
Original Filing: 300872975.xml
Lobbying Issues
Issues related to Medicaid pharmacy reimbursement and services access
Issues related to medication therapy management
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to Drug Enforcement Agency and its efforts on prescription drug abuse and diversion.
Comprehensive Drug Addiction and Recovery Act (S. 524)
Pharmacy issues within TriCARE
Issues related to scope of services for pharmacists
Agencies Lobbied
U.S. Senate
4th Quarter, 2016
In Q4, Lincoln Policy Group lobbied for National Association of Chain Drug Stores , earning $50,000. The report was filed on Jan. 23, 2017.
Original Filing: 300854694.xml
Lobbying Issues
Issues related to Medicaid pharmacy reimbursement and services access
Issues related to Medication Therapy Management
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to Drug Enforcement Agency and its efforts on prescription drug abuse and diversion
Comprehensive Drug Addiction and Recovery Act (S. 524)
Pharmacy issues within TriCARE
Issues related to scope of services for pharmacists
Agencies Lobbied
U.S. Senate
3rd Quarter, 2016
In Q3, Lincoln Policy Group lobbied for National Association of Chain Drug Stores , earning $50,000. The report was filed on Oct. 20, 2016.
Original Filing: 300835411.xml
Lobbying Issues
Issues related to Medicaid pharmacy reimbursement and services access
Issues related to Medication Therapy Management
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to Drug Enforcement Agency and its efforts on prescription drug abuse and diversion
Comprehensive Drug Addiction and Recovery Act (S. 524)
Pharmacy issues within TriCARE
Issues related to scope of services for pharmacists
Agencies Lobbied
U.S. Senate
2nd Quarter, 2016
In Q2, Lincoln Policy Group lobbied for National Association of Chain Drug Stores , earning $50,000. The report was filed on July 20, 2016.
Original Filing: 300818639.xml
Lobbying Issues
Issues related to Medicaid pharmacy reimbursement and services access
Issues related to Medication Therapy Management
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to Drug Enforcement Agency and its efforts on prescription drug abuse and diversion
Comprehensive Drug Addiction and Recovery Act (S. 524)
Pharmacy issues within TriCARE
Issues related to scope of services for pharmacists
Agencies Lobbied
U.S. Senate
1st Quarter, 2016
In Q1, Lincoln Policy Group lobbied for National Association of Chain Drug Stores , earning $50,000. The report was filed on April 20, 2016.
Original Filing: 300799769.xml
Lobbying Issues
Issues related to Medicaid pharmacy reimbursement and services access
Issues related to Medication Therapy Management
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to Drug Enforcement Agency and its efforts on prescription drug abuse and diversion
Pharmacy issues within TriCARE
Issues related to scope of services for pharmacists
Agencies Lobbied
U.S. Senate
1st Quarter, 2016
Lincoln Policy Group filed a lobbying registration on Jan. 26, 2016 to represent National Association of Chain Drug Stores, effective Jan. 1, 2016.
Original Filing: 300785310.xml
Issue(s) they said they’d lobby about: Issues related to scope of services for pharmacists
Issues related to pharmacy reimbursements and Medication Therapy Management
Issues related to Medicaid pharmacy reimbursement and services access
Issues related to Drug Enforcement Agency and its efforts on prescription drug abuse and diversion.
Pharmacy issues within TriCARE .
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate
Searching...